Company
Baxdela
Broad Coverage for ABSSSI: gram-positive pathogens, including MRSA, and gram-negative pathogens, including Pseudomonas aeruginosa
- Status
- Operatingas of 2026-09-17
Record updated 17 September 2026
About
BAXDELA is indicated in adults for the treatment of acute bacterial skin and skin structure infections. BAXDELA is indicated in adults for the treatment of community-acquired bacterial pneumonia.
Products
- Other
- Baxdela